Inflammatix, Inc.

Inflammatix is developing an innovative point-of-care instrument platform to be used with a rapid (<30-minute) test to aid in the diagnosis of acute infection and sepsis by harnessing the immune system to deliver advanced immune response diagnostics. Our test rapidly informs the clinician about the likelihood of bacterial or viral infection and the need for ICU level care in the emergency department. Faster results may translate into more timely and appropriate therapy and level of care decisions for better patient outcomes. *Products in development, are not for sale, and do not have marketing approval or clearance from regulatory authorities in any jurisdiction.